Skip to content
Episode 200 -- Brian Kaspar PhD episode artwork

Apr 10, 2019 45 min

Episode 200 -- Brian Kaspar PhD

from Neuroscientists Talk Shop Hosted by Neuroscientists Talk Shop

Wednesday, April 10, 2019 Brian Kaspar (AveXis Inc) talks about the realities and promise of building a single-dose gene transfer therapy for treating the prime gene defect in spinal muscular atrophy (SMA) type I. He discusses his company’s modified adeno-associated virus 9 approach to human gene therapy that is currently in highly promising clinical trials, for SMA, and in development for Rett syndrome and one variant of Amyotrophic Lateral Sclerosis. Duration: 45 minutes Discussants:(in alphabetical order) Jenny Hsieh (Semmes Foundation Chair, UTSA) Salma Quraishi (Res Asst Prof, UTSA) Charles Wilson (Ewing Halsell Chair, UTSA) acknowledgement: JM Tepper for original music.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Episode 200 -- Brian Kaspar PhD

0:00 45:34

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Neuroscientists Talk Shop?

This episode is 45 minutes long.

When was this Neuroscientists Talk Shop episode published?

This episode was published on April 10, 2019.

Can I download this Neuroscientists Talk Shop episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.